Jill Morris, PhD
Dr. Morris is the program director at the National Institute of Neurological Disorders and Stroke (NINDS). Her disease research portfolio consists of multiple neurological disorders comprising Tourette syndrome; the leukodystrophies and lysosomal storage disorders; inborn errors of metabolism; neural tube defects; hydrocephalus; neurofibromatosis; and mitochondrial disorders. Her basic grant portfolio includes glia biology and neural crest cells. She is also responsible for methodology grants regarding gene therapy/delivery/RNAi technology.
Prior to coming to the NIH, she was an assistant professor in the Department of Pediatrics in the Feinberg School of Medicine at Northwestern University and Children’s Memorial Research Center. Her laboratory studied and published multiple papers on the function of DISC1, a schizophrenia susceptibility gene.
Previously, she was senior research biologist in the Department of Neuroscience at Merck Research Laboratories where she directed research projects relating to bipolar affective disorder, schizophrenia, Alzheimer’s disease and Parkinson’s disease. Prior to Merck, she was a senior staff fellow in the Unit of Molecular Neurogenetics at the National Institutes of Health where her research led to the identification and characterization of the gene responsible for the autosomal recessive neurodegenerative disorder called Niemann-Pick type C disease.